Diagnostic Accuracy and Prognostic Value of 18F FDG PET-CT in Follow-Up of Colorectal Carcinoma
Summary
NIH ClinicalTrials.gov registered observational study NCT07536321 evaluating the diagnostic and prognostic value of 18F FDG PET-CT imaging in the follow-up of patients with Stage III rectal cancer. The 5-year prospective study will enroll participants already undergoing routine PET-CT imaging and assess whether PET-CT contributes to treatment decision-making in colorectal cancer patients.
What changed
NIH registered a new observational clinical study (NCT07536321) on ClinicalTrials.gov examining the role of 18F FDG PET-CT imaging in the follow-up care of patients with Stage III rectal cancer. The study aims to determine whether PET-CT provides diagnostic and prognostic value that influences treatment decisions for colorectal carcinoma patients.
For healthcare providers and research institutions, this registry entry represents an ongoing clinical investigation into advanced imaging utilization in oncology care. Clinical sites may encounter increased enrollment opportunities, and researchers studying colorectal cancer diagnostics should monitor findings for potential impact on standard imaging protocols. The 5-year follow-up duration indicates longitudinal data collection that may inform future diagnostic guidelines.
Archived snapshot
Apr 17, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
Diagnostic Accuracy and Prognostic Value of 18F FDG PET-CT in the Follow up of Patients With Colorectal Carcinoma.
Observational NCT07536321 Kind: OBSERVATIONAL Apr 17, 2026
Abstract
The goal of this observational study is to learn about the diagnostic and prognostic value of 18f fdg pet ct in follow up of colorectal cancer patients The main question it aims to answer is:
Does pet ct have a role in treatment decision in colorectal cancer patients? Participants already be undergoing for pet ct as part of their follow up routine and will be followed up for 5 years.
Conditions: Rectal Cancer (Stage III)
Related changes
Get daily alerts for ClinicalTrials.gov Studies
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from NIH.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when ClinicalTrials.gov Studies publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.